ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/04/12 | 2,182 | 2,194 | 2,159 | 2,165 | -21 | -1% | 55,200 |
2018/04/11 | 2,217 | 2,217 | 2,162 | 2,186 | -22 | -1% | 71,200 |
2018/04/10 | 2,200 | 2,236 | 2,186 | 2,208 | -1 | ±0% | 116,200 |
2018/04/09 | 2,189 | 2,230 | 2,189 | 2,209 | +28 | +1.3% | 95,400 |
2018/04/06 | 2,168 | 2,187 | 2,140 | 2,181 | +15 | +0.7% | 88,600 |
2018/04/05 | 2,162 | 2,180 | 2,148 | 2,166 | +22 | +1% | 73,800 |
2018/04/04 | 2,103 | 2,149 | 2,095 | 2,144 | +29 | +1.4% | 96,700 |
2018/04/03 | 2,096 | 2,122 | 2,079 | 2,115 | +8 | +0.4% | 62,700 |
2018/04/02 | 2,129 | 2,139 | 2,101 | 2,107 | -21 | -1% | 57,000 |
2018/03/30 | 2,160 | 2,160 | 2,105 | 2,128 | -2 | -0.1% | 58,300 |
2018/03/29 | 2,130 | 2,142 | 2,088 | 2,130 | +10 | +0.5% | 111,700 |
2018/03/28 | 2,086 | 2,122 | 2,064 | 2,120 | +1 | ±0% | 111,500 |
2018/03/27 | 2,034 | 2,120 | 2,029 | 2,119 | +100 | +5% | 195,600 |
2018/03/26 | 2,009 | 2,022 | 1,998 | 2,019 | +10 | +0.5% | 198,400 |
2018/03/23 | 2,001 | 2,026 | 2,001 | 2,009 | -33 | -1.6% | 191,200 |
2018/03/22 | 2,029 | 2,044 | 2,005 | 2,042 | +21 | +1% | 98,900 |
2018/03/20 | 2,020 | 2,035 | 2,004 | 2,021 | ±0 | ±0% | 90,300 |
2018/03/19 | 2,017 | 2,026 | 2,001 | 2,021 | -3 | -0.1% | 60,400 |
2018/03/16 | 2,059 | 2,059 | 2,022 | 2,024 | -17 | -0.8% | 74,100 |
2018/03/15 | 2,075 | 2,075 | 2,033 | 2,041 | -19 | -0.9% | 46,600 |
2018/03/14 | 2,084 | 2,084 | 2,047 | 2,060 | -27 | -1.3% | 78,300 |
2018/03/13 | 2,040 | 2,089 | 2,036 | 2,087 | +47 | +2.3% | 64,100 |
2018/03/12 | 2,049 | 2,049 | 2,027 | 2,040 | +15 | +0.7% | 48,200 |
2018/03/09 | 2,050 | 2,050 | 2,011 | 2,025 | +7 | +0.3% | 127,500 |
2018/03/08 | 2,062 | 2,062 | 2,009 | 2,018 | -1 | ±0% | 39,300 |
2018/03/07 | 2,021 | 2,052 | 2,012 | 2,019 | -4 | -0.2% | 51,800 |
2018/03/06 | 2,034 | 2,050 | 2,018 | 2,023 | +2 | +0.1% | 55,200 |
2018/03/05 | 2,018 | 2,033 | 2,006 | 2,021 | +1 | ±0% | 56,800 |
2018/03/02 | 2,046 | 2,061 | 2,010 | 2,020 | -58 | -2.8% | 91,000 |
2018/03/01 | 2,091 | 2,097 | 2,071 | 2,078 | -18 | -0.9% | 103,400 |
2018/02/28 | 2,112 | 2,130 | 2,096 | 2,096 | -31 | -1.5% | 79,600 |
2018/02/27 | 2,150 | 2,150 | 2,116 | 2,127 | -14 | -0.7% | 47,400 |
2018/02/26 | 2,130 | 2,147 | 2,125 | 2,141 | +33 | +1.6% | 43,100 |
2018/02/23 | 2,117 | 2,117 | 2,093 | 2,108 | -1 | ±0% | 54,500 |
2018/02/22 | 2,091 | 2,112 | 2,075 | 2,109 | -1 | ±0% | 96,000 |
2018/02/21 | 2,140 | 2,153 | 2,104 | 2,110 | -38 | -1.8% | 73,800 |
2018/02/20 | 2,107 | 2,154 | 2,107 | 2,148 | +42 | +2% | 69,500 |
2018/02/19 | 2,145 | 2,150 | 2,100 | 2,106 | ±0 | ±0% | 53,000 |
2018/02/16 | 2,075 | 2,121 | 2,075 | 2,106 | +36 | +1.7% | 65,200 |
2018/02/15 | 2,060 | 2,076 | 2,049 | 2,070 | +11 | +0.5% | 80,500 |
2018/02/14 | 2,063 | 2,080 | 2,038 | 2,059 | -6 | -0.3% | 84,600 |
2018/02/13 | 2,115 | 2,120 | 2,055 | 2,065 | -33 | -1.6% | 130,800 |
2018/02/09 | 2,081 | 2,117 | 2,081 | 2,098 | -46 | -2.1% | 102,100 |
2018/02/08 | 2,134 | 2,180 | 2,096 | 2,144 | +3 | +0.1% | 149,900 |
2018/02/07 | 2,100 | 2,259 | 2,100 | 2,141 | +131 | +6.5% | 314,900 |
2018/02/06 | 2,035 | 2,053 | 1,982 | 2,010 | -96 | -4.6% | 215,700 |
2018/02/05 | 2,135 | 2,146 | 2,097 | 2,106 | -59 | -2.7% | 148,800 |
2018/02/02 | 2,181 | 2,187 | 2,142 | 2,165 | -37 | -1.7% | 113,300 |
2018/02/01 | 2,191 | 2,213 | 2,182 | 2,202 | +8 | +0.4% | 81,700 |
2018/01/31 | 2,220 | 2,246 | 2,194 | 2,194 | -30 | -1.3% | 79,600 |
1801~
1850
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム